Literature DB >> 23220685

Antipsychotic drugs are associated with pulseless electrical activity: the Oregon Sudden Unexpected Death Study.

Carmen Teodorescu1, Kyndaron Reinier, Audrey Uy-Evanado, Harpriya Chugh, Karen Gunson, Jonathan Jui, Sumeet S Chugh.   

Abstract

BACKGROUND: There has been a paradigm shift in the manifestation of sudden cardiac arrest (SCA), with steadily decreasing rates of ventricular fibrillation/tachycardia (VF/VT) and a significant increase in the proportion of pulseless electrical activity (PEA) and asystole.
OBJECTIVE: Since PEA is marked by failure of myocardial contractility, we evaluated the potential role of drugs that affect cardiac contractility in the pathophysiology of human PEA.
METHODS: Subjects with out-of-hospital SCA (aged≥18 years) who underwent attempted resuscitation were evaluated in the ongoing Oregon Sudden Unexpected Death Study (2002-2009). Specific classes of medications with either negative or positive cardiac inotropic effects were evaluated for association with occurrence of PEA vs VF/VT by using Pearson χ(2) tests and logistic regression.
RESULTS: PEA cases (n = 309) were older than VF/VT cases (n = 509; 68±14 years vs 64±15 years; P<.0001) and were more likely to be women (39% vs 25%; P<.0001). In a logistic regression model adjusting for age, sex, comorbidities, disease burden, and resuscitation variables, antipsychotic drugs (odds ratio 2.40; 95% confidence interval 1.26-4.53) were significant predictors of PEA vs VF/VT. Conversely, use of digoxin was associated with the occurrence of VF/VT (P<.0001).
CONCLUSIONS: When drugs modifying myocardial contractility were evaluated in a comprehensive analysis of patients who suffered SCA, use of antipsychotic agents was a significant and independent predictor of manifestation with PEA.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220685     DOI: 10.1016/j.hrthm.2012.12.002

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  6 in total

1.  Antipsychotic medications and sudden cardiac arrest: more than meets the eye?

Authors:  James Peacock; William Whang
Journal:  Heart Rhythm       Date:  2012-12-28       Impact factor: 6.343

Review 2.  Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Jules C Hancox; Adrian Baranchuk; Geneviève C Digby; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Anand Deshmukh; Ananda K Pandurangi
Journal:  Psychopharmacology (Berl)       Date:  2013-06-30       Impact factor: 4.530

3.  Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries.

Authors:  Carlo A Barcella; Talip E Eroglu; Michiel Hulleman; Asger Granfeldt; Patrick C Souverein; Grimur H Mohr; Rudolph W Koster; Mads Wissenberg; Anthonius de Boer; Christian Torp-Pedersen; Fredrik Folke; Marieke T Blom; Gunnar H Gislason; Hanno L Tan
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

4.  Association of non-shockable initial rhythm and psychotropic medication in sudden cardiac arrest.

Authors:  Janna P Kauppila; Antti Hantula; Lasse Pakanen; Juha S Perkiömäki; Matti Martikainen; Heikki V Huikuri; M Juhani Junttila
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-22

5.  Sudden cardiac arrest in patients with schizophrenia: A population-based study of resuscitation outcomes and pre-existing cardiovascular disease.

Authors:  Gabriel G Edwards; Audrey Uy-Evanado; Eric C Stecker; Angelo Salvucci; Jonathan Jui; Sumeet S Chugh; Kyndaron Reinier
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-08

6.  Unexpected High Prevalence of Cardiovascular Disease Risk Factors and Psychiatric Disease Among Young People With Sudden Cardiac Arrest.

Authors:  Katherine S Allan; Laurie J Morrison; Arnold Pinter; Jack V Tu; Paul Dorian
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.